Sovran Advisors’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.17M Buy
61,643
+4,134
+7% +$78.7K 0.12% 182
2025
Q1
$3.09M Buy
57,509
+30,494
+113% +$1.64M 0.4% 62
2024
Q4
$3.21M Buy
+27,015
New +$3.21M 0.46% 55